Romana E. Mikes
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2017
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
Journal: NPJ primary care respiratory medicine
Published: May 26, 2016
First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 06, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026